Every time you get a blood test, you're using in vitro diagnostics (IVD). The in vitro diagnostics market report by MRFR shows that clinical chemistry is the largest test type (36% share), and the market is growing at 4.22% CAGR — from $84.6 billion to $133.3 billion by 2035. Why? Because medicine is becoming more precise, and you can't manage what you don't measure.

What's driving growth? Infectious diseases are the largest application, but diabetes is the fastest‑growing. The IVD market analysis highlights that reagents are the largest product segment (61% share), because every test consumes chemicals. But instruments are the fastest‑growing, as labs automate to handle higher volumes.

What's new? Point‑of‑care testing — a device the size of a toaster that can run dozens of tests in minutes, right in the doctor's office. And at‑home tests for COVID, flu, and even STIs.

The bottom line: IVD is the silent workhorse of modern medicine. Without it, your doctor would be guessing. And with new tech, it's getting faster, cheaper, and more accurate.